Startseite Medizin MicroRNA let-7g directly targets forkhead box C2 (FOXC2) to modulate bone metastasis in breast cancer
Artikel Open Access

MicroRNA let-7g directly targets forkhead box C2 (FOXC2) to modulate bone metastasis in breast cancer

  • Lei Wang , Ming Li , Yongxin Zhou und Yu Zhao EMAIL logo
Veröffentlicht/Copyright: 6. September 2017
Artikel downloaden (PDF)
Open Medicine
Aus der Zeitschrift Open Medicine Band 12 Heft 1

Abstract

Aberrantly expressed microRNAs have been implicated in lots of cancers. Reduced amounts of let-7g have been found in breast cancer tissues. The function of let-7g in bone metastasis of breast cancer remains poorly understood. This study is to explore the significance of let-7g and its novel target gene in bone metastasis of breast cancer.

The expression of let-7g or forkhead box C2 (FOXC2) was measured in human clinical breast cancer tissues with bone metastasis by using quantitative real-time Polymerase Chain Reaction (qRT-PCR). After transfection with let-7g or anti-let-7g in breast cancer cell linesMDA-MB-231or SK-BR3, qRT-PCR and Western blot were done to test the levels of let-7g and FOXC2. The effect of anti-let-7g and/ or FOXC2 RNA interference (RNAi) on cell migration in breast cancer cells was evaluated by using wound healing assay.

Clinically, qRT-PCR showed that FOXC2 levels were higher in breast cancer tissues with bone metastasis than those in their noncancerous counterparts. Let-7g was showed to be negatively correlated with FOXC2 in human breast cancer samples with bone metastasis. We found that enforced expression of let-7g reduced levels of FOXC2 protein by using Western blot in MDA-MB-231 cells. Conversely, anti-let-7g enhanced levels of FOXC2 in SK-BR3 cells. In terms of function, anti-let-7g accelerated migration of SK-BR3 cells. Interestingly, FOXC2 RNAi abrogated anti-let-7g-mediated migration in breast cancer cells. Thus, we conclude that let-7g suppresses cell migration through targeting FOXC2 in breast cancer. Our finding provides a new perspective for understanding the mechanism of bone metastasis in breast cancer.

Keywords: let-7g; FOXC2; Migration; Bone metastasis; Breast cancer

1 Introduction

Breast cancer is the most common cancer among women [1]. MicroRNAs (miRNAs) usually modulate the expression of target genes at the post-transcription level [2-4]. As one of the first tumor suppressor miRNAs to be identified, the let-7 family is composed of 13 members with overlapping and distinct functions in humans [5-7]. A report shows that let-7 expression is decreased and RAS protein is significantly higher in lung tumors [8], which is consistent with clinical observations in lung cancer [9]. A number of groups found inhibitory functions of the let-7 family in various types of tumors [6, 7, 10]. Reduced let-7 expression is reported to be associated with shortened postoperative survival in patients with cancer [11]. Let-7 is capable of targeting many oncogenic proteins, such as KRAS/HRAS [8, 12, 13], HMGA2 [13-16], and cyclin genes [17, 18]. Let-7g, one member of let-7 family, is involved in the development of hepatocellular carcinoma and breast cancer [19, 20]. Let-7g plays important roles in liver cancer through negatively regulating Bcl-xL or collagen type I α2 [19, 21]. However, the underlying mechanism by which let-7g functions in breast cancer metastasis remains unclear.

The transcription factor superfamily Forkhead-box (FOX) plays a role in differentiation, proliferation, migration, apoptosis, and metabolism [22, 23]. The change in FOX expression is involved in progression of various cancers through affecting epithelial–mesenchymal transition (EMT) or EMT regulatory pathways [24]. One member of FOX, FOXA1, is shown to be highly expressed in breast cancer [25]. FOXC2, another member, is able to promote metastasis and paclitaxel drug resistance [26, 27].

In the present study, we investigated the role of let-7g and its novel target gene in bone metastasis of breast cancer. We show that let-7g is negatively related to FOXC2 in breast tissues with bone metastasis and suppresses cell migration through regulating FOXC2 in breast cancer. Our finding contributes to understanding the mechanism of breast cancer metastasis mediated by let-7g.

2 Materials and methods

2.1 Patient samples

Twenty-five cases of clinical breast tumor tissues with bone metastasis and their corresponding peritumor tissues were obtained from the First Affiliated Hospital of Xi’an Medical University (Xi’an, China) after surgical resection. The patients consented that samples could be used for research. Patient information is listed in Table S1. Research Ethics Committee at the First Affiliated Hospital of Xi’an Medical University approved the study protocol.

Table S1

Clinical characteristics of breast tumor samples

No.AgeSexOrganPathology diagnosisGrade
0156FBreastNonspecific infiltrating ductal carcinoma with bone metastasisI
0247FBreastLittle nonspecific infiltrating ductal carcinoma with bone metastasisI
0334FBreastNonspecific infiltrating ductal carcinoma with bone metastasisI
0433FBreastNonspecific infiltrating ductal carcinoma with bone metastasisI
0538FBreastA little nonspecific infiltrating ductal carcinoma with bone metastasisI
0646FBreastLittle nonspecific infiltrating ductal carcinoma with bone metastasisII
0743FBreastNonspecific infiltrating ductal carcinoma with bone metastasisII
0848FBreastLittle nonspecific infiltrating ductal carcinoma with bone metastasisII
0953FBreastNonspecific infiltrating ductal carcinoma with bone metastasisII
1062FBreastNonspecific infiltrating ductal carcinoma with bone metastasisII
1134FBreastLittle nonspecific infiltrating ductal carcinoma with bone metastasisII
1257FBreastNonspecific infiltrating ductal carcinoma with bone metastasisII
1336FBreastNonspecific infiltrating ductal carcinoma with bone metastasisII
1452FBreastNonspecific infiltrating ductal carcinoma with bone metastasisII
1551FBreastNonspecific infiltrating ductal carcinoma with bone metastasisIII
1649FBreastNonspecific infiltrating ductal carcinoma with bone metastasisII
1740FBreastNonspecific infiltrating ductal carcinoma with bone metastasisII
1852FBreastNonspecific infiltrating ductal carcinoma with bone metastasisII
1948FBreastNonspecific infiltrating ductal carcinoma with bone metastasisII
2035FBreastNonspecific infiltrating ductal carcinoma with bone metastasisII
2139FBreastNonspecific infiltrating ductal carcinoma with bone metastasisII
2240FBreastNonspecific infiltrating ductal carcinoma with bone metastasisII
2345FBreastLittle nonspecific infiltrating ductal carcinoma with bone metastasisII
2433FBreastNonspecific infiltrating ductal carcinoma with bone metastasisII
2553FBreastNonspecific infiltrating ductal carcinoma with bone metastasisI-II

2.2 Cell lines

Breast cancer cell lines MDA-MB-231 with high metastatic ability and SK-BR3 were grown in Dulbecco’s modified Eagle’s medium with 10% fetal bovine serum (Gibco, CA, USA). Cells were incubated at 37°C., 5% CO2.

2.3 Quantitative real-time polymerase chain reaction (qRT-PCR)

Total RNA was purified by Trizol (Invitrogen, USA). To test let-7g poly (A) polymerase (Ambion, USA) was added to polyadenylate total RNA. SuperScript™ IV Reverse Transcriptase (ThermoFisher Scientific, USA) was used to do reverse transcription. The primers used were as follows: FOXC2 forward, 5′-CCTACC TGAGCGAGCAGAAT-3′, reverse, 5′-ACCTTGACGA AGCACTCGTT-3′; GAPDH forward, 5′-AACGGATTTGGTCGTATTG-3′, reverse, 5′-GGAAGATGGTGATGGGATT-3′; let-7g forward, 5′- CTGTACAGGCCACTGCCTTGC-3′, reverse, 5′-GCGAGCACAGAATTAATACGAC-3′; U6 forward, 5′-CTCGCTTCGGCAGCACA-3′, reverse, 5′-AACTCTTCACTAATTTGCTG-3′.

2.4 Cell transfection

Lipofectamine 2000 reagent (Invitrogen, USA) was used to transfect miRNAs or siRNAs. Let-7g, anti-let-7g, and siFOXC2 (5′-GCAGTCTTATCTAACTATGATGCAA-3′) were synthesized by Sangon Biotech (Shanghai, China).

2.5 Western blot

Cells were lysed and proteins were extracted in RIPA buffer (Biomed, China). Equal amounts of protein were separated by SDS-PAGE and transferred to membranes. Membranes were blotted with anti-β-actin (NeoMarkers, USA) and anti-FOXC2 (Abcam, USA). Membranes were finally visualized by ImmobilonTM Western Chemiluminescent HRP Substrate (Millipore Corporation, USA).

Wound healing assay Breast

cancer cells were seeded into 6-well plates. Sterile plastic pipette tip was utilized to make a wound. Pictures of the wound were taken at 0h and 48h post scraping. At each time point the wound gaps were measured.

2.6 Statistical analysis

Each experiment was performed in triplicate. By comparing mean values (±SD) using a Student’s t test, statistical significance was estimated for independent groups (⋆⋆P < 0.01, ⋆⋆⋆P < 0.001). The correlation of let-7g with FOXC2 in clinical breast cancer tissues with bone metastasis was determined by Pearson’s correlation coefficient.

3 Results

3.1 Let-7g is negatively related to FOXC2 in breast cancer patients with bone metastasis

Our data showed that FOXC2 was highly expressed in 25 breast tumor samples with bone metastasis compared with peritumor samples (Figure. 1A). Furthermore, qRT-PCR analysis showed a negative correlation of let-7g with FOXC2 in clinical breast cancer tissues with bone metastasis (Pearson’s correlation coefficient r=-0.8982, p<0.001) (Figure. 1B), indicating that FOXC2 might be one target gene of let-7g in breast cancer. These results suggest that let-7g negatively correlates with FOXC2 in breast cancer tissues with bone metastasis.

Figure 1 Let-7g negatively correlates with FOXC2 in human breast cancer samples with bone metastasis. (A) FOXC2 expression was tested by qRT-PCR in 25 breast tumor tissues with bone metastasis and peritumor tissues. (B) The association of let-7g with FOXC2 was analyzed by qRT-PCR in 25 breast cancer tissues with bone metastasis (Pearson’s correlation coefficient, r=-0.8982). (Statistical differences: *** P < 0.001; Student’s t test)
Figure 1

Let-7g negatively correlates with FOXC2 in human breast cancer samples with bone metastasis. (A) FOXC2 expression was tested by qRT-PCR in 25 breast tumor tissues with bone metastasis and peritumor tissues. (B) The association of let-7g with FOXC2 was analyzed by qRT-PCR in 25 breast cancer tissues with bone metastasis (Pearson’s correlation coefficient, r=-0.8982). (Statistical differences: *** P < 0.001; Student’s t test)

3.2 Let-7g is able to inhibit FOXC2 in breast cancer cells

To explore the modulation of FOXC2 by let-7g we transfected let-7g into MDA-MB-231 cells. We observed that let-7g could decrease the level of FOXC2 protein in MDA-MB-231 cells (Figure. 2A). Nevertheless, FOXC2 was rescued when anti-let-7g transfection depressed endogenous let-7g in SK-BR3 cells (Figure. 2B), further supporting that let-7g is critical for FOXC2 regulation in the cells. Transfection validation of let-7g and anti-let-7g by qRT-PCR analysis was performed in the cells (Figure. 2A and 2B). Our data illustrate that let-7g is likely to repress FOXC2 in breast cancer cells.

Figure 2 Let-7g inhibits FOXC2 expression in breast cancer cells. (A) The levels of FOXC2 protein were examined in MDA-MB-231 cells with the treatment of let-7g by Western blot analysis. The successful transfection of let-7g was confirmed by qRT-PCR analysis. (B) The levels of FOXC2 protein were determined in SK-BR3 cells with anti-let-7g treatment using Western blot. The successful transfection of anti-let-7g was accessed by qRT-PCR. (Statistical differences: ** P < 0.01, *** P < 0.001; Student’s t test)
Figure 2

Let-7g inhibits FOXC2 expression in breast cancer cells. (A) The levels of FOXC2 protein were examined in MDA-MB-231 cells with the treatment of let-7g by Western blot analysis. The successful transfection of let-7g was confirmed by qRT-PCR analysis. (B) The levels of FOXC2 protein were determined in SK-BR3 cells with anti-let-7g treatment using Western blot. The successful transfection of anti-let-7g was accessed by qRT-PCR. (Statistical differences: ** P < 0.01, *** P < 0.001; Student’s t test)

3.3 Let-7g reduces migration of breast cancer cells via FOXC2

Next, we tried to clarify the function of let-7g in breast cancer. Wound healing assays revealed that cell migration was increased post-transfection with anti-let-7g in SK-BR3 cells, while FOXC2 knockdown abolished the induced-migration mediated by anti-let-7g (Figure. 3A and 3B). In general, our data indicate that let-7g is capable of inhibiting cell migration through FOXC2 in breast cancer cells.

Figure 3 Let-7g reduces cell migration via FOXC2 in breast cancer. (A, B) Wound healing assays for anti-let-7g (or anti-let-7g/siFOXC2) effect on cell migration was performed in SK-BR3 cells. Scale bar = 10 μm. (Statistical differences: ** P < 0.01; Student’s t test)
Figure 3

Let-7g reduces cell migration via FOXC2 in breast cancer. (A, B) Wound healing assays for anti-let-7g (or anti-let-7g/siFOXC2) effect on cell migration was performed in SK-BR3 cells. Scale bar = 10 μm. (Statistical differences: ** P < 0.01; Student’s t test)

4 Discussion

MiRNAs play important roles in multiple biological processes. MiRNAs take the roles of oncogenes or tumor suppressor genes through different mechanisms. Many studies show that let-7 is the most frequently found miRNA and is significantly related to clinical outcomes in cancers [11]. Some nanoparticle-based let-7 replacement therapy has been successfully tested in preclinical animal models of cancer [12, 28-31]. The functional characterization of the let-7 family in cancer represents a great opportunity to develop robust biomarkers and novel therapeutic strategies for this disease. Therefore, we are interested in the role of let-7g and its novel target gene in bone metastasis of breast cancer.

In our present study, we found that as one member of the FOX transcription factor family, FOXC2 was obviously up-regulated in clinical breast cancer tissues with bone metastasis. Moreover, a significant correlation between let-7g and FOXC2 was observed in clinical breast cancer samples. Ectopicly expressed let-7g significantly inhibited the expression of FOXC2 in breast cancer cells. Functionally, anti-let-7g promoted the migration of breast cancer cells in vitro. However, silencing of FOXC2 could abrogate the increase of cell migration induced by anti-let-7g in breast cancer.

Accumulating evidence shows that the expression of let-7 is usually lost, reduced, or deregulated in the majority of human cancers [2]. A report shows that restoration of let-7 expression inhibits proliferation of cancer cells of different kinds [8]. LIN28 induced-suppression of let-7 maturation mediated by TUTase is a potential target for pharmacologic inhibition by small chemical compounds [32]. Some let-7 family members have been reported to be negatively correlated with metastasis in cancers [19, 20, 33-35]. Notably, let-7g was specifically linked with breast cancer metastasis and poor patient survival [20]. Our results suggest that let-7g might be an ideal therapeutic target in breast cancer. Given every miRNA is capable of targeting many transcripts, the potential regulation in cancer afforded by the let-7 family might be different. Let-7 could reduce tumor cell migration via ITGB3 and MYH9 [33, 36]. The chemotactic response during tumor metastasis can be blocked by let-7 through CCR7 and CXCR4 [35, 37]. FOXC2 is one member of FOX transcription factor superfamily. FOXC2 could sensitize stem cell-rich breast cancer cells to PLK1 inhibition and induce the G2/M transition [38]. Recently, a report has showed that FOXC2 regulates EMT and metastasis in a p38-dependent manner in breast cancer [39]. We found that FOXC2 was a novel target gene of let-7g in breast cancer metastasis.

We presented a novel target gene of let-7g in driving bone metastasis of breast cancer. We found the negative correlation of FOXC2 and let-7g in clinical breast cancer tissues with bone metastasis. Let-7g is able to negatively regulate FOXC2 to inhibit cell migration in breast cancer. Therapeutically, the let-7g/FOXC2 axis might be a potential target for breast cancer treatment.

  1. Conflict of interest: There are no conflicts of interest.

References

[1] Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D., Global cancer statistics, CA Cancer J Clin., 2011,61(2),69-9010.3322/caac.20107Suche in Google Scholar PubMed

[2] Yates L.A., Norbury C.J., Gilbet R.J., The long and short of microRNA, Cell., 2013,153(3),516-51910.1016/j.cell.2013.04.003Suche in Google Scholar PubMed

[3] Wei Y., Schober A., Weber C., Pathogenic arterial remodeling: the good and bad of microRNAs, Am J Physiol Heart Circ Physiol., 2013,304(8), H1050-105910.1152/ajpheart.00267.2012Suche in Google Scholar PubMed

[4] Wang Z., Yao H., Lin S., Zhu X., Shen Z., Lu G., et al., Transcriptional and epigenetic regulation of human microRNAs, Cancer Lett., 2013,331(1),1-1010.1016/j.canlet.2012.12.006Suche in Google Scholar PubMed

[5] Pasquinelli A.E., Reinhart B.J., Slack F., Martindale M.Q., Kuroda M.I., Maller B., et al., Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA, Nature, 2000,408(6808),86-8910.1038/35040556Suche in Google Scholar PubMed

[6] Bussing I., Slack F.J., Grosshans H., let-7 microRNAs in development, stem cells and cancer, Trends Mol Med. 2008,14(9),400-40910.1016/j.molmed.2008.07.001Suche in Google Scholar PubMed

[7] Roush S., Slack F.J., The let-7 family of microRNAs, Trends Cell Biol., 2008,18(10),505-51610.1016/j.tcb.2008.07.007Suche in Google Scholar PubMed

[8] Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., et al., RAS is regulated by the let-7 microRNA family. Cell., 2005,120(5),635-64710.1016/j.cell.2005.01.014Suche in Google Scholar PubMed

[9] Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., et al., Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival, Cancer Res., 2004,64(11),3753-375610.1158/0008-5472.CAN-04-0637Suche in Google Scholar PubMed

[10] Boyerinas B., Park S.M., Hau A., Murmann A.E., Peter M.E., The role of let-7 in cell differentiation and cancer, Endocr Relat Cancer., 2010,17(1), F19-3610.1677/ERC-09-0184Suche in Google Scholar PubMed

[11] Nair V.S., Maeda L.S., loannidis J.P., Clinical outcome prediction by microRNAs in human cancer: a systematic review, J Natl Cancer Inst., 2012,104(7),528-54010.1093/jnci/djs027Suche in Google Scholar PubMed PubMed Central

[12] Kumar M,S,, Erkeland S,J,, Pester R,E,, Chen C,Y,, Ebert M,S,, Sharp P,A,, et al., Suppression of non-small cell lung tumor development by the let-7 microRNA family, Proc Natl Acad Sci U S A., 2008,105(10),3903-390810.1073/pnas.0712321105Suche in Google Scholar PubMed PubMed Central

[13] Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., et al., let-7 regulates self renewal and tumorigenicity of breast cancer cells, Cell., 2007,131(6),1109-112310.1016/j.cell.2007.10.054Suche in Google Scholar PubMed

[14] Mayr C., Hemann MT, Bartel D.P., Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation, Science., 2007,315(5818),1576-157910.1126/science.1137999Suche in Google Scholar PubMed PubMed Central

[15] Lee Y.S., Dutta A., The tumor suppressor microRNA let-7 represses the HMGA2 oncogene, Genes Dev., 2007,21(9),1025-103010.1101/gad.1540407Suche in Google Scholar PubMed PubMed Central

[16] Peng Y., Laser J., Shi G., Mittal K., Melamed J., Lee P., et al., Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma, Mol Cancer Res., 2008,6(4),663-67310.1158/1541-7786.MCR-07-0370Suche in Google Scholar PubMed

[17] Schultz J., Lorenz P., Gross G., Ibrahim S., Kunz M., MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth, Cell Res., 2008,18(5),549-55710.1038/cr.2008.45Suche in Google Scholar PubMed

[18] Johnson C.D., Esquela-Kerscher A., Stefani G., Byrom M., Kelnar K., Ovcharenko D., et al., The let-7 microRNA represses cell proliferation pathways in human cells, Cancer Res., 2007,67(16),7713-772210.1158/0008-5472.CAN-07-1083Suche in Google Scholar PubMed

[19] Ji J., Zhao L., Budhu A., Forgues M., Jia H.L., Qin L.X., et al., Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma, J Hepatol., 2010,52(5),690-69710.1016/j.jhep.2009.12.025Suche in Google Scholar PubMed PubMed Central

[20] Qian P., Zuo Z., Wu Z., Meng X., Li G., Wu Z., et al., Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis, Cancer Res., 2011,71(20),6463-647410.1158/0008-5472.CAN-11-1322Suche in Google Scholar PubMed

[21] Shimizu S., Takehara T., Hikita H., Kodama T., Miyagi T., Hosui A., et al., The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma, J Hepatol., 2010,52(5),698-70410.1016/j.jhep.2009.12.024Suche in Google Scholar PubMed

[22] Myatt S.S., Lam E.W., The emerging roles of forkhead box (Fox) proteins in cancer, Nat Rev Cancer, 2007,7(11),847-85910.1038/nrc2223Suche in Google Scholar PubMed

[23] Wijchers P.J., Burbach J.P., Smidt M.P., In control of biology: of mice, men and Foxes, Biochem J., 2006,397(2),233-24610.1042/BJ20060387Suche in Google Scholar PubMed PubMed Central

[24] Katoh M., Igarashi M., Fukuda H., Nakagama H., Katoh M., Cancer genetics and genomics of human FOX family genes, Cancer Lett., 2013,328(2),198-20610.1016/j.canlet.2012.09.017Suche in Google Scholar PubMed

[25] Bernardo G.M., Bebek G., Ginther C.L., Sizemore S.T., Lozada K.L., Miedler J.D., et al., FOXA1 represses the molecular phenotype of basal breast cancer cells. Oncogene.,2013,32(5),554-56310.1038/onc.2012.62Suche in Google Scholar PubMed PubMed Central

[26] Mani S.A., Yang J., Brooks M., Schwaninger G., Zhou A., Miura N., et al., Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers, Proc Natl Acad Sci U S A., 2007,104(24),10069-1007410.1073/pnas.0703900104Suche in Google Scholar PubMed PubMed Central

[27] Hollier B.G., Tinnirello A.A., Werden S.J., Evans K.W., Taube J.H., Sarkar T.R., et al., FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Res., 2013,73(6),1981-199210.1158/0008-5472.CAN-12-2962Suche in Google Scholar PubMed PubMed Central

[28] Esquela-Kerscher A., Trang ., Wiggins J.F., Patrawala L., Cheng A., Ford L., et al., The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle., 2008,7(6),759-76410.4161/cc.7.6.5834Suche in Google Scholar PubMed

[29] Trang P., Medina P.P., Wiggins J.F., Ruffino L., Kelnar K., Omotola M., et al., Regression of murine lung tumors by the let-7 microRNA, Oncogene., 2010,29(11),1580-158710.1038/onc.2009.445Suche in Google Scholar PubMed PubMed Central

[30] Trang P., Wiggins J.F., Daige C.L., Cho C., Omotola M., Brown D., et al., Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice, Mol Ther., 2011,19(6),1116-112210.1038/mt.2011.48Suche in Google Scholar PubMed PubMed Central

[31] Wang Y., Hu X., Greshock J., Shen L., Yang X., Shao Z., et al., Genomic DNA copy-number alterations of the let-7 family in human cancers, PLoS One., 2012,7(9), e4439910.1371/journal.pone.0044399Suche in Google Scholar PubMed PubMed Central

[32] Viswanathan S.R., Daley G.Q., Lin28: A microRNA regulator with a macro role, Cell., 2010,140(4),445-44910.1016/j.cell.2010.02.007Suche in Google Scholar PubMed

[33] Muller D.W., Bosserhoff A.K., Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma, Oncogene., 2008,27(52),6698-670610.1038/onc.2008.282Suche in Google Scholar PubMed

[34] Han H.B., Gu J., Zuo H.J., Chen Z.G., Zhao W., Li M., et al., Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer, J Pathol., 2012,226(3),544-55510.1002/path.3014Suche in Google Scholar PubMed

[35] Yun J., Frankenberger C.A., Kuo W.L., Boelens M.C., Eves E.M., Cheng N., et al., Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer, EMBO J., 2011,30(21),4500-451410.1038/emboj.2011.312Suche in Google Scholar PubMed PubMed Central

[36] Liang S., He L., Zhao X., Miao Y., Gu Y., Guo C., et al., MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. PloS one,2011,6(4), e1840910.1371/journal.pone.0018409Suche in Google Scholar PubMed PubMed Central

[37] Kim S.J., Shin J.Y., Lee K.D., Bae Y.K., Sung K.W., Nam S.J., et al., MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7, Breast Cancer Res., 2012,14(1),R1410.1186/bcr3098Suche in Google Scholar PubMed PubMed Central

[38] Pietila M., Vijay G.V., Soundararajan R., Yu X., Symmans W.F., Sphyris N., et al., FOXC2 regulates the G2/M transition of stem cell-rich breast cancer cells and sensitizes them to PLK1 inhibition. Sci Rep., 2016,6,2307010.1038/srep23070Suche in Google Scholar PubMed PubMed Central

[39] Werden S.J., Sphyris N., Sarkar T.R., Paranjape A.N., LaBaff A.M., Taube J.H., et al., Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth, Oncogene, 2016,35(46),5977-598810.1038/onc.2016.203Suche in Google Scholar PubMed PubMed Central

Received: 2017-3-24
Accepted: 2017-4-8
Published Online: 2017-9-6

© 2017 Lei Wang et al.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Artikel in diesem Heft

  1. Regular Articles
  2. Intravascular treatment of left subclavian artery aneurysm coexisting with aortic coarctation in an adult patient
  3. Regular Articles
  4. Effect of electrical stimulation on blood flow velocity and vessel size
  5. Regular Articles
  6. Live birth pregnancy outcome after first in vitro fertilization treatment in a patient with Systemic Lupus Erythematosus and isolated high positive IgA anti-β2glycoprotein I antibodies: a case report
  7. Regular Articles
  8. Periodontal ligament stem cells regulate apoptosis of neutrophils
  9. Regular Articles
  10. Platelet-rich fibrin (PRF) in implants dentistry in combination with new bone regenerative flapless technique: evolution of the technique and final results
  11. Regular Articles
  12. The significance of strong ion gap for predicting return of spontaneous circulation in patients with cardiopulmonary arrest
  13. Regular Articles
  14. Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma
  15. Regular Articles
  16. Intraosseous lipoma of the mandibula: A case report and review of the literature
  17. Regular Articles
  18. Transurethral resection of the prostate, bladder explosion and hyponatremic encephalopathy: a rare case report of malpractice
  19. Regular Articles
  20. Brain strokes related to aortic aneurysma – the analysis of three cases
  21. Regular Articles
  22. Effect of Bicyclol tablets on drug induced liver injuries after kidney transplantation
  23. Regular Articles
  24. Plasma free fatty acids in hyperemesis gravidarum pregnancy
  25. Regular Articles
  26. Impact of chromosomal rearrangement upon DNA methylation patterns in leukemia
  27. Regular Articles
  28. Gefitinib versus docetaxel in treated non-small-cell lung cancer: a meta-analysis
  29. Regular Articles
  30. The clinical characteristics of patients with chronic idiopathic anal pain
  31. Regular Articles
  32. Bone tunnel impaction reduced the tibial tunnel enlargement
  33. Regular Articles
  34. Effects of S-1 combined with radiotherapy in the treatment of nasopharyngeal cancer: a meta-analysis based on randomized controlled trials
  35. Regular Articles
  36. Predictions and outcomes of atrial fibrillation in the patients with acute myocardial infarction
  37. Regular Articles
  38. An accuracy study of the Intracavitary Electrocardiogram (IC-ECG) guided peripherally inserted central catheter tip placement among neonates
  39. Regular Articles
  40. Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis
  41. Regular Articles
  42. Surface coil intensity correction in magnetic resonance imaging in spinal metastases
  43. Regular Articles
  44. Muscle stem cell and physical activity: what point is the debate at?
  45. Regular Articles
  46. MicroRNA let-7g directly targets forkhead box C2 (FOXC2) to modulate bone metastasis in breast cancer
  47. Regular Articles
  48. Monitoring health inequalities at the municipal level: Lithuanian experience
  49. Regular Articles
  50. Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
  51. Regular Articles
  52. Thrombectomy combined with indwelling-catheter thrombolysis is more effective than pure thrombectomy for the treatment of lower extremity deep venous thrombosis
  53. Regular Articles
  54. Expression of Hepcidin and Neogenin in colorectal cancer
  55. Regular Articles
  56. Carnitine and adiponectin levels in breast cancer after radiotherapy
  57. Regular Articles
  58. Pathophysiology of meningioma growth in pregnancy
  59. Regular Articles
  60. Causal neuro-immune relationships at patients with chronic pyelonephritis and cholecystitis. Correlations between parameters EEG, HRV and white blood cell count
  61. Regular Articles
  62. Measuring efficiency of secondary healthcare providers in Slovenia
  63. Regular Articles
  64. Galectin-3 expression in colorectal cancer and its correlation with clinical pathological characteristics and prognosis
  65. Regular Articles
  66. Model for studying anti- allergic drugs for allergic conjunctivitis in animals
  67. Regular Articles
  68. Barriers perceived by nurses in the optimal treatment of postoperative pain
  69. Regular Articles
  70. Tumor microenvironment in treatment of glioma
  71. Regular Articles
  72. Delirium risk of dexmedetomidine and midazolam in patients treated with postoperative mechanical ventilation: A meta-analysis
  73. Regular Articles
  74. Hemangioma of the rib: a rare case report and literature review
  75. Regular Articles
  76. The diagnostic accuracy of conventional forceps biopsy compared to ESD
  77. Regular Articles
  78. Increased miR-25 expression in serum of gastric cancer patients is correlated with CA19-9 and acts as a potential diagnostic biomarker
  79. Regular Articles
  80. Therapeutic nanomedicine surmounts the limitations of pharmacotherapy
  81. Regular Articles
  82. Relationship between PD-L1 expression and clinical characteristics in patients with breast invasive ductal carcinoma
  83. Regular Articles
  84. Trypsinogen activation peptide induces HMGB1 release from rat pancreatic acinar cells
  85. Regular Articles
  86. The effective regulation of pro- and anti-inflammatory cytokines induced by combination of PA-MSHA and BPIFB1 in initiation of innate immune responses
  87. Regular Articles
  88. Cell based therapeutic approach in vascular surgery: application and review
  89. Regular Articles
  90. Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy
  91. Regular Articles
  92. Professional burnout and concurrent health complaints in neonatal nursing
  93. Regular Articles
  94. Esophageal xanthoma: presence of M2 macrophages suggests association with late inflammatory and reparative processes
  95. Regular Articles
  96. Cone beam computed tomography analysis in 3D position of maxillary denture
  97. Regular Articles
  98. CK20 mRNA expression in serum as a biomarker for colorectal cancer diagnosis: A meta-analysis
  99. Regular Articles
  100. Serum AFU, 5’-NT and AFP as biomarkers for primary hepatocellular carcinoma diagnosis
  101. Regular Articles
  102. Absolute reliability and concurrent validity of hand held dynamometry and isokinetic dynamometry in the hip, knee and ankle joint: systematic review and meta-analysis
  103. Regular Articles
  104. The Fountain of Youth: A tale of parabiosis, stem cells, and rejuvenation
  105. Regular Articles
  106. Foam sclerotherapy during shunt surgery for portal hypertension and varices
  107. Regular Articles
  108. Insomnia and depression: Japanese hospital workers questionnaire survey
  109. Regular Articles
  110. Serum NF-κBp65, TLR4 as biomarker for diagnosis of preeclampsia
  111. Regular Articles
  112. Docetaxel/cisplatin therapy in myasthenia gravis with hypertension/diabetes
  113. Regular Articles
  114. Fluid resuscitation and markers of glycocalyx degradation in severe sepsis
  115. Regular Articles
  116. Modified Sauve-Kapandji procedure for patients with old fractures of the distal radius
  117. Regular Articles
  118. Bile leakage after liver transplantation
  119. Regular Articles
  120. VEGF overexpression predicts poor survival in hepatocellular carcinoma
  121. Regular Articles
  122. Galen vein aneurysm– challenge for treatment
  123. Regular Articles
  124. Retrieval of a broken sewing needle from the sacrum aided by a permanent magnet: a case report and literature review
  125. Regular Articles
  126. HIV/STI prevention interventions: A systematic review and meta-analysis
  127. Regular Articles
  128. Aortic aneurysm as a complication of myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis
  129. Regular Articles
  130. Real-time monitoring of contrast-enhanced ultrasound for radio frequency ablation
  131. Regular Articles
  132. Successful drug-eluting stent implantation in a male patient with dextrocardia: a case report
  133. Regular Articles
  134. Primary pleomorphic liposarcoma of fallopian tube with recurrence: a case report and review of the literature
  135. Regular Articles
  136. Color Doppler Ultrasound in Uterine Arterial Embolization
  137. Regular Articles
  138. Pattern of alcohol consumption by young people from North Eastern Portugal
  139. Regular Articles
  140. Effects of out-of-hospital continuing nursing on schizophrenia patients' rehabilitation and quality of life
https://doi.org/10.1515/med-2017-0023
Schlagwörter für diesen Artikel
let-7g; FOXC2; Migration; Bone metastasis; Breast cancer
Creative Commons
BY-NC-ND 3.0

Artikel in diesem Heft

  1. Regular Articles
  2. Intravascular treatment of left subclavian artery aneurysm coexisting with aortic coarctation in an adult patient
  3. Regular Articles
  4. Effect of electrical stimulation on blood flow velocity and vessel size
  5. Regular Articles
  6. Live birth pregnancy outcome after first in vitro fertilization treatment in a patient with Systemic Lupus Erythematosus and isolated high positive IgA anti-β2glycoprotein I antibodies: a case report
  7. Regular Articles
  8. Periodontal ligament stem cells regulate apoptosis of neutrophils
  9. Regular Articles
  10. Platelet-rich fibrin (PRF) in implants dentistry in combination with new bone regenerative flapless technique: evolution of the technique and final results
  11. Regular Articles
  12. The significance of strong ion gap for predicting return of spontaneous circulation in patients with cardiopulmonary arrest
  13. Regular Articles
  14. Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma
  15. Regular Articles
  16. Intraosseous lipoma of the mandibula: A case report and review of the literature
  17. Regular Articles
  18. Transurethral resection of the prostate, bladder explosion and hyponatremic encephalopathy: a rare case report of malpractice
  19. Regular Articles
  20. Brain strokes related to aortic aneurysma – the analysis of three cases
  21. Regular Articles
  22. Effect of Bicyclol tablets on drug induced liver injuries after kidney transplantation
  23. Regular Articles
  24. Plasma free fatty acids in hyperemesis gravidarum pregnancy
  25. Regular Articles
  26. Impact of chromosomal rearrangement upon DNA methylation patterns in leukemia
  27. Regular Articles
  28. Gefitinib versus docetaxel in treated non-small-cell lung cancer: a meta-analysis
  29. Regular Articles
  30. The clinical characteristics of patients with chronic idiopathic anal pain
  31. Regular Articles
  32. Bone tunnel impaction reduced the tibial tunnel enlargement
  33. Regular Articles
  34. Effects of S-1 combined with radiotherapy in the treatment of nasopharyngeal cancer: a meta-analysis based on randomized controlled trials
  35. Regular Articles
  36. Predictions and outcomes of atrial fibrillation in the patients with acute myocardial infarction
  37. Regular Articles
  38. An accuracy study of the Intracavitary Electrocardiogram (IC-ECG) guided peripherally inserted central catheter tip placement among neonates
  39. Regular Articles
  40. Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis
  41. Regular Articles
  42. Surface coil intensity correction in magnetic resonance imaging in spinal metastases
  43. Regular Articles
  44. Muscle stem cell and physical activity: what point is the debate at?
  45. Regular Articles
  46. MicroRNA let-7g directly targets forkhead box C2 (FOXC2) to modulate bone metastasis in breast cancer
  47. Regular Articles
  48. Monitoring health inequalities at the municipal level: Lithuanian experience
  49. Regular Articles
  50. Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
  51. Regular Articles
  52. Thrombectomy combined with indwelling-catheter thrombolysis is more effective than pure thrombectomy for the treatment of lower extremity deep venous thrombosis
  53. Regular Articles
  54. Expression of Hepcidin and Neogenin in colorectal cancer
  55. Regular Articles
  56. Carnitine and adiponectin levels in breast cancer after radiotherapy
  57. Regular Articles
  58. Pathophysiology of meningioma growth in pregnancy
  59. Regular Articles
  60. Causal neuro-immune relationships at patients with chronic pyelonephritis and cholecystitis. Correlations between parameters EEG, HRV and white blood cell count
  61. Regular Articles
  62. Measuring efficiency of secondary healthcare providers in Slovenia
  63. Regular Articles
  64. Galectin-3 expression in colorectal cancer and its correlation with clinical pathological characteristics and prognosis
  65. Regular Articles
  66. Model for studying anti- allergic drugs for allergic conjunctivitis in animals
  67. Regular Articles
  68. Barriers perceived by nurses in the optimal treatment of postoperative pain
  69. Regular Articles
  70. Tumor microenvironment in treatment of glioma
  71. Regular Articles
  72. Delirium risk of dexmedetomidine and midazolam in patients treated with postoperative mechanical ventilation: A meta-analysis
  73. Regular Articles
  74. Hemangioma of the rib: a rare case report and literature review
  75. Regular Articles
  76. The diagnostic accuracy of conventional forceps biopsy compared to ESD
  77. Regular Articles
  78. Increased miR-25 expression in serum of gastric cancer patients is correlated with CA19-9 and acts as a potential diagnostic biomarker
  79. Regular Articles
  80. Therapeutic nanomedicine surmounts the limitations of pharmacotherapy
  81. Regular Articles
  82. Relationship between PD-L1 expression and clinical characteristics in patients with breast invasive ductal carcinoma
  83. Regular Articles
  84. Trypsinogen activation peptide induces HMGB1 release from rat pancreatic acinar cells
  85. Regular Articles
  86. The effective regulation of pro- and anti-inflammatory cytokines induced by combination of PA-MSHA and BPIFB1 in initiation of innate immune responses
  87. Regular Articles
  88. Cell based therapeutic approach in vascular surgery: application and review
  89. Regular Articles
  90. Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy
  91. Regular Articles
  92. Professional burnout and concurrent health complaints in neonatal nursing
  93. Regular Articles
  94. Esophageal xanthoma: presence of M2 macrophages suggests association with late inflammatory and reparative processes
  95. Regular Articles
  96. Cone beam computed tomography analysis in 3D position of maxillary denture
  97. Regular Articles
  98. CK20 mRNA expression in serum as a biomarker for colorectal cancer diagnosis: A meta-analysis
  99. Regular Articles
  100. Serum AFU, 5’-NT and AFP as biomarkers for primary hepatocellular carcinoma diagnosis
  101. Regular Articles
  102. Absolute reliability and concurrent validity of hand held dynamometry and isokinetic dynamometry in the hip, knee and ankle joint: systematic review and meta-analysis
  103. Regular Articles
  104. The Fountain of Youth: A tale of parabiosis, stem cells, and rejuvenation
  105. Regular Articles
  106. Foam sclerotherapy during shunt surgery for portal hypertension and varices
  107. Regular Articles
  108. Insomnia and depression: Japanese hospital workers questionnaire survey
  109. Regular Articles
  110. Serum NF-κBp65, TLR4 as biomarker for diagnosis of preeclampsia
  111. Regular Articles
  112. Docetaxel/cisplatin therapy in myasthenia gravis with hypertension/diabetes
  113. Regular Articles
  114. Fluid resuscitation and markers of glycocalyx degradation in severe sepsis
  115. Regular Articles
  116. Modified Sauve-Kapandji procedure for patients with old fractures of the distal radius
  117. Regular Articles
  118. Bile leakage after liver transplantation
  119. Regular Articles
  120. VEGF overexpression predicts poor survival in hepatocellular carcinoma
  121. Regular Articles
  122. Galen vein aneurysm– challenge for treatment
  123. Regular Articles
  124. Retrieval of a broken sewing needle from the sacrum aided by a permanent magnet: a case report and literature review
  125. Regular Articles
  126. HIV/STI prevention interventions: A systematic review and meta-analysis
  127. Regular Articles
  128. Aortic aneurysm as a complication of myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis
  129. Regular Articles
  130. Real-time monitoring of contrast-enhanced ultrasound for radio frequency ablation
  131. Regular Articles
  132. Successful drug-eluting stent implantation in a male patient with dextrocardia: a case report
  133. Regular Articles
  134. Primary pleomorphic liposarcoma of fallopian tube with recurrence: a case report and review of the literature
  135. Regular Articles
  136. Color Doppler Ultrasound in Uterine Arterial Embolization
  137. Regular Articles
  138. Pattern of alcohol consumption by young people from North Eastern Portugal
  139. Regular Articles
  140. Effects of out-of-hospital continuing nursing on schizophrenia patients' rehabilitation and quality of life
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2026 De Gruyter Brill
Heruntergeladen am 25.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/med-2017-0023/html
Button zum nach oben scrollen